These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 14722744)

  • 1. New insights on preventing and managing peritonitis.
    Piraino B
    Pediatr Nephrol; 2004 Feb; 19(2):125-7. PubMed ID: 14722744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
    Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
    Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing peritoneal dialysis related infections.
    Piraino B
    Minerva Urol Nefrol; 2006 Jun; 58(2):161-9. PubMed ID: 16767069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes in peritoneal dialysis: impact of continuous quality provement initiatives.
    Qamar M; Sheth H; Bender FH; Piraino B
    Adv Perit Dial; 2009; 25():76-9. PubMed ID: 19886322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
    Bernardini J; Bender F; Florio T; Sloand J; Palmmontalbano L; Fried L; Piraino B
    J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of infectious complications in peritoneal dialysis: best demonstrated practices.
    Bender FH; Bernardini J; Piraino B
    Kidney Int Suppl; 2006 Nov; (103):S44-54. PubMed ID: 17080111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit site.
    Uttley L; Vardhan A; Mahajan S; Smart B; Hutchison A; Gokal R
    J Nephrol; 2004; 17(2):242-5. PubMed ID: 15293524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of peritonitis in peritoneal dialysis.
    Segal JH; Messana JM
    Semin Dial; 2013; 26(4):494-502. PubMed ID: 23859192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fivefold reduction in peritonitis using a multifaceted continuous quality initiative program.
    Borg D; Shetty A; Williams D; Faber MD
    Adv Perit Dial; 2003; 19():202-5. PubMed ID: 14763063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do topical antibiotics reduce exit site infection rates and peritonitis episodes in peritoneal dialysis patients? The Pan Thames Renal Audit.
    Davenport A;
    J Nephrol; 2012; 25(5):819-24. PubMed ID: 22241640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Catheter-related interventions to prevent peritonitis in peritoneal dialysis: guideline from the Italian Society of Nephrology].
    De Vecchi A; Corciulo R; Salomone M; Russo R; Amici A; D'Amico M; Feriani M; La Milia V; Virga G; Cancarini G;
    G Ital Nefrol; 2007; 24 Suppl 37():S136-48. PubMed ID: 17347962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey of peritonitis and exit-site and/or tunnel infections in Japanese children on PD.
    Hoshii S; Wada N; Honda M;
    Pediatr Nephrol; 2006 Jun; 21(6):828-34. PubMed ID: 16518629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of topical mupirocin on peritoneal dialysis infection rates in Singapore General Hospital.
    Lim CT; Wong KS; Foo MW
    Nephrol Dial Transplant; 2005 Aug; 20(8):1702-6. PubMed ID: 15855200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: a review of 104 cases.
    Szeto CC; Chow KM; Leung CB; Wong TY; Wu AK; Wang AY; Lui SF; Li PK
    Kidney Int; 2001 Jun; 59(6):2309-15. PubMed ID: 11380835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of weekly mupirocin application on infections in continuous ambulatory peritoneal dialysis patients.
    Zeybel M; Ozder A; Sanlidag C; Yildiz S; Cavdar C; Ersoy R; Celik A; Camsari T
    Adv Perit Dial; 2003; 19():198-201. PubMed ID: 14763062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis.
    Mahaldar A; Weisz M; Kathuria P
    Adv Perit Dial; 2009; 25():56-9. PubMed ID: 19886318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of topical mupirocin on peritoneal dialysis infection in Singapore General Hospital.
    Lim CT; Wong KS; Foo MW
    Nephrol Dial Transplant; 2005 Oct; 20(10):2202-6. PubMed ID: 16046516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of once-a-week vs thrice-a-week application of mupirocin on methicillin and mupirocin resistance in peritoneal dialysis patients: three years of experience.
    Cavdar C; Saglam F; Sifil A; Celik A; Atay T; Gungor O; Ozder A; Gulay Z; Camsari T
    Ren Fail; 2008; 30(4):417-22. PubMed ID: 18569916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antimicrobial agents for preventing peritonitis in peritoneal dialysis: guideline from the Italian Society of Nephrology].
    Amici G; Russo R; Feriani M; Corciulo R; D'Amico M; De Vecchi A; La Milia V; Salomone M; Virga G; Cancarini G;
    G Ital Nefrol; 2007; 24 Suppl 37():S125-35. PubMed ID: 17347961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies to universally improve peritonitis rates, including use of dialysis solutions with low glucose degradation products.
    Diaz-Buxo JA; Himmele R
    Adv Perit Dial; 2010; 26():37-40. PubMed ID: 21348377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.